Teunissen, Charlotte E.
Malekzadeh, Arjan
Leurs, Cyra
Bridel, Claire
Killestein, Joep
Article History
First Online: 22 September 2015
Competing interests
: C.E.T. serves on the advisory board of Fujirebio and Roche, has received research consumables from Fujirebio, Euroimmun, IBL, Invitrogen and Mesoscale Discovery, and has performed contract research for Boehringer, IBL, Probiodrug, Roche and Shire. J.K. has received consulting and speaker fees from Biogen, Genzyme, Novartis, Merck-Serono and TEVA. The VUMC MS Center Amsterdam has received financial support for research activities from Bayer Schering Pharma, Biogen Idec, Genzyme, Glaxo Smith Kline, Merck Serono, Novartis, and Teva. The other authors declare no competing interests.